98 related articles for article (PubMed ID: 8672995)
1. Altered aromatic amine metabolism in epileptic patients treated with phenobarbital.
Wallin H; Skipper PL; Tannenbaum SR; Jensen JP; Rylander L; Olsen JH
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):771-3. PubMed ID: 8672995
[TBL] [Abstract][Full Text] [Related]
2. Nonsmoking-related arylamine exposure and bladder cancer risk.
Skipper PL; Tannenbaum SR; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
[TBL] [Abstract][Full Text] [Related]
3. Phenobarbital, drug metabolism, and human cancer.
Olsen JH; Wallin H; Boice JD; Rask K; Schulgen G; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):449-52. PubMed ID: 8220089
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
5. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples.
Myers SR; Spinnato JA; Pinorini-Godly MT; Cook C; Boles B; Rodgers GC
J Toxicol Environ Health; 1996 Apr; 47(6):553-66. PubMed ID: 8614023
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
8. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
[TBL] [Abstract][Full Text] [Related]
9. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
[TBL] [Abstract][Full Text] [Related]
10. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
11. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
[TBL] [Abstract][Full Text] [Related]
12. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
13. Bulky DNA adducts and risk of cancer: a meta-analysis.
Veglia F; Matullo G; Vineis P
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):157-60. PubMed ID: 12582026
[TBL] [Abstract][Full Text] [Related]
14. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
Airoldi L; Vineis P; Colombi A; Olgiati L; Dell'Osta C; Fanelli R; Manzi L; Veglia F; Autrup H; Dunning A; Garte S; Hainaut P; Hoek G; Krzyzanowski M; Malaveille C; Matullo G; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Järvholm B; Hallmans G; Day NE; Allen N; Saracci R; Kaaks R; Riboli E
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2118-24. PubMed ID: 16172219
[TBL] [Abstract][Full Text] [Related]
15. Bladder cancer epidemiology and pathogenesis.
Ross RK; Jones PA; Yu MC
Semin Oncol; 1996 Oct; 23(5):536-45. PubMed ID: 8893866
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
Besaratinia A; Tommasi S
FASEB J; 2013 Jun; 27(6):2090-100. PubMed ID: 23449930
[TBL] [Abstract][Full Text] [Related]
17. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer.
Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191
[TBL] [Abstract][Full Text] [Related]
18. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
19. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
20. Carcinogen: DNA adducts in tobacco smoke-associated cancer of the upper respiratory tract.
Szyfter K; Banaszewski J; Jałoszyński P; Pabiszczak M; Szyfter W; Szmeja Z
Acta Biochim Pol; 1999; 46(2):275-87. PubMed ID: 10547029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
